We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.
Learn moreOK
MenuSearch: Home
Roche welcomes the updated recommendation of the Subject Expert Committee (SEC) on Tecentriq for metastatic Urothelial Cancer (mUC)